Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

2.

Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study.

Hoeller S, Zhou Y, Kanagal-Shamanna R, Xu-Monette ZY, Hoehn D, Bihl M, Swerdlow SH, Rosenwald A, Ott G, Said J, Dunphy CH, Bueso-Ramos CE, Lin P, Wang M, Miranda RN, Tzankov A, Medeiros LJ, Young KH.

Hum Pathol. 2013 Jan;44(1):110-21. doi: 10.1016/j.humpath.2012.04.022. Epub 2012 Aug 31. Review.

3.
4.

CD23 and chronic lymphocytic leukemia.

Sarfati M.

Blood Cells. 1993;19(3):591-6; discussion 597-9. Review.

PMID:
8018941
5.

CD5+ true SLL/CLL with plasmacytic differentiation and an unusual 1p36 translocation: case report and review of the literature.

Evans HL, Polski JM, Deshpande V, Dunphy CH.

Leuk Lymphoma. 2000 Nov;39(5-6):625-32. Review.

PMID:
11342346
6.

Adhesion molecules in B-chronic lymphoproliferative disorders.

Angelopoulou MK, Kontopidou FN, Pangalis GA.

Semin Hematol. 1999 Apr;36(2):178-97. Review.

PMID:
10319387
7.

Mantle cell lymphomas.

Rodriguez MA, Pugh WC.

Cancer Treat Res. 1996;85:41-50. Review.

PMID:
9043774
8.

Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?

Giné E, Bosch F, Villamor N, Rozman M, Colomer D, López-Guillermo A, Campo E, Montserrat E.

Leukemia. 2002 Aug;16(8):1454-9. Review.

9.

Small lymphocytic lymphoma and chronic lymphocytic leukemia: are they the same disease?

Santos FP, O'Brien S.

Cancer J. 2012 Sep-Oct;18(5):396-403. Review.

PMID:
23006943
10.

Primary manifestation of small lymphocytic lymphoma in the prostate.

Fehr M, Templeton A, Cogliatti S, Aebersold F, Egli F, Gillessen S, Cathomas R.

Onkologie. 2009 Oct;32(10):586-8. doi: 10.1159/000232584. Epub 2009 Sep 11. Review.

PMID:
19816076
11.

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Monoclonal B-Cell Lymphocytosis.

Hasserjian RP.

Surg Pathol Clin. 2010 Dec;3(4):907-31. doi: 10.1016/j.path.2010.09.009. Epub 2010 Nov 27. Review.

PMID:
26839294
12.

Differential diagnosis of malignant lymphomas and related disorders by specific pattern of expression of immunophenotypic markers revealed by multiparameter flow cytometry (Review).

Weisberger J, Wu CD, Liu Z, Wong JY, Melamed MR, Darzynkiewicz Z, Gorczyca W.

Int J Oncol. 2000 Dec;17(6):1165-77. Review.

PMID:
11078802
13.

Pathology of indolent B-cell neoplasms other than follicular lymphoma.

Sakata S, Tsuyama N, Takeuchi K.

J Clin Exp Hematop. 2014;54(1):11-22. Review.

14.

[Non-Hodgkin's lymphomas (from Rappaport to WHO 2001 and nowadays). Review].

Macák J, Plank L.

Cesk Patol. 2007 Apr;43(2):39-49. Review. Czech.

PMID:
17623975
15.

CD23: novel disease marker with a split personality.

Gordon J.

Clin Exp Immunol. 1991 Dec;86(3):356-9. Review. No abstract available.

16.

[Phenotypic classification of malignant lymphoma].

Kaneita Y, Yasukawa K, Kura Y, Yamazaki T, Sawada U.

Nihon Rinsho. 2000 Mar;58(3):586-90. Review. Japanese.

PMID:
10741129
17.

Transformation in Low-grade B-cell Neoplasms.

Montgomery ND, Mathews SP.

Surg Pathol Clin. 2016 Mar;9(1):79-92. doi: 10.1016/j.path.2015.09.004. Review.

PMID:
26940269
18.

Idelalisib: The First-in-Class Phosphatidylinositol 3-Kinase Inhibitor for Relapsed CLL, SLL, and Indolent NHL.

Forcello N, Saraiya N.

J Adv Pract Oncol. 2014 Nov-Dec;5(6):455-9. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk